TABLE 3.

Molecular characterization of MRCPS

Strain	Species	Groupa	Resistance to OXAb	SCCmec type	Toxin type	PFGE pattern
						SmaI	AscI
NVAU06003	MRSA	Human	H	II	tst, sec, seg, sei	X1	NDd
NVAU06030	MRSA	Dog-i	H	II	tst, sec, seg, sei	X2	ND
NVAU06032	MRSA	Human	H	IV	None	Y	ND
NVAU06013	MRSP	Human	H	III	None	A4	a1
NVAU06021	MRSP	Dog-o	H	III	None	B2	a4
NVAU06029	MRSP	Dog-o	H	III	None	C2	a1
NVAU06002	MRSP	Dog-o	H	III	None	D	a1
NVAU06018	MRSP	Dog-o	H	III	None	D	a1
NVAU06037	MRSP	Dog-o	H	NTc	None	E	a3
NVAU06046	MRSP	Dog-o	L	NT	None	H	a6
NVAU06016	MRSP	Dog-i	H	III	None	A2	a1
NVAU06017	MRSP	Dog-i	H	III	None	A3	a1
NVAU06022	MRSP	Dog-i	H	III	None	B3	a3
NVAU06031	MRSP	Dog-i	H	III	None	C1	a1
NVAU06039	MRSP	Dog-i	H	III	None	C3	a1
NVAU06045	MRSP	Dog-i	L	V	None	F	a5
NVAU06043	MRSP	Dog-i	H	NT	None	A1	a1
NVAU06044	MRSP	Dog-i	H	NT	None	A1	a1
NVAU06034	MRSP	Dog-I	H	NT	None	B1	a1
NVAU06033	MRSP	Dog-i	H	NT	None	B4	a2
NVAU06038	MRSP	Dog-i	L	NT	None	G	a6

^aDog-o and Dog-i refer to outpatient and inpatient dogs, respectively.

^bH, high-level resistance to OXA (MIC of ≥128 μg/ml); L, low-level resistance to OXA (MIC of 0.5 to 64 μg/ml).

^cNT, nontypeable.

^dND, not done.